In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-11-23
MYMDMymd Pharmaceuticals, Inc.Rivard PaulEVP of Operations, GCP - Purchase$6.03+15,000215,000+8%+$90,450
2021-11-22
ABIOArca Biopharma, Inc.Ozeroff Christopher DavidS.VP, GCP - Purchase$2.26+50,00050,970>999%+$113,210
2021-11-23
HSKAHeska CorpWilson Kevin S.CEO, PresP - Purchase$173.00+1,000398,3330%+$173,000
2021-11-16
VNRXVolitionrx LtdButera Salvatore ThomasCEO-Volition VeterinaryP - Purchase$4.02+10,000167,000+6%+$40,200
2021-11-15
LNTHLantheus Holdings, Inc.Sabens AndreaChief Accounting OfficerS - Sale$30.47-1,24263,586-2%-$37,844
D
2021-11-15
CLDXCelldex Therapeutics, Inc.Martin Samuel BatesSVP, CFOS - Sale+OE$43.57-9,50026,878-26%-$413,883
D
2021-11-12
CLDXCelldex Therapeutics, Inc.Young Diane C.SVP, Chief Medical OfficerS - Sale+OE$42.94-4,6002,115-69%-$197,529
2021-11-15
HSKAHeska CorpWilson Kevin S.CEO, PresP - Purchase$179.00+1,000397,3330%+$179,000
D
2021-11-12
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$620.73-9,22544,367-17%-$5,726,188
2021-11-10
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$30.12-13,333674,849-2%-$401,646
D
2021-11-10
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$624.96-20,00044,367-31%-$12,499,279
DM
2021-11-08
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$629.05-16,31044,367-27%-$10,259,809
D
2021-11-05
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical OfficerS - Sale+OE$132.72-2,4008,714-22%-$318,535
D
2021-11-01
QTNTQuotient LtdVon Prondzynski HeinoDirS - Sale+OE$0.00-3,713294,099-1%-$0
D
2021-11-01
QTNTQuotient LtdMcDonough BrianDirS - Sale+OE$0.00-1,236114,910-1%-$0
D
2021-11-01
CLDXCelldex Therapeutics, Inc.Cavanaugh SarahSVP of Corp Affairs, Admin.S - Sale+OE$43.26-7,323408-95%-$316,804
D
2021-11-01
CLDXCelldex Therapeutics, Inc.Crowley ElizabethSVP,CPDOS - Sale+OE$43.29-4,3174,726-48%-$186,874
D
2021-11-01
CLDXCelldex Therapeutics, Inc.Heath-Chiozzi MargoSVP of Regulatory AffairsS - Sale+OE$41.71-60011,247-5%-$25,026
M
2021-10-18
LNTHLantheus Holdings, Inc.Montagut EtienneChief Business OfficerS - Sale$22.92-4,11283,594-5%-$94,245
M
2021-10-18
LNTHLantheus Holdings, Inc.Marshall Robert J. Jr.CFO, TreasurerS - Sale$22.92-9,502127,007-7%-$217,832
2021-10-15
LNTHLantheus Holdings, Inc.Sabens AndreaChief Accounting OfficerS - Sale$23.71-1,24264,828-2%-$29,448
D
2021-10-15
OCDXOrtho Clinical Diagnostics Holdings PlcSchlesinger Michael A.EVP, GC, SecretaryS - Sale+OE$19.73-75,46487,637-46%-$1,489,010
D
2021-10-14
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical OfficerS - Sale+OE$128.44-2,4008,714-22%-$308,249
D
2021-10-11
NTLAIntellia Therapeutics, Inc.Crowley John FDirS - Sale+OE$119.55-2,5002,094-54%-$298,875
D
2021-10-05
NTLAIntellia Therapeutics, Inc.Crowley John FDirS - Sale+OE$130.54-10,0002,094-83%-$1,305,391
2021-10-01
MYGNMyriad Genetics IncLambert NicoleSee RemarksS - Sale$31.57-1,420176,652-1%-$44,835
DM
2021-09-29
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$43.80-18,66427,939-40%-$817,432
D
2021-09-30
NEOGNeogen CorpLilly Jason WarrenVPS - Sale+OE$43.72-15,99820,000-44%-$699,450
2021-09-27
MYGNMyriad Genetics IncLambert NicoleSee RemarksS - Sale$33.10-10,112178,072-5%-$334,747
2021-09-23
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale$35.06-200275,1350%-$7,012
2021-09-23
NEOGNeogen CorpTobin James PDirP - Purchase$42.92+1,00012,000+9%+$42,920
D
2021-09-21
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical OfficerS - Sale+OE$149.81-2,400791-75%-$359,544
D
2021-09-17
MYGNMyriad Genetics IncHart Jayne B.Chief People OfficerS - Sale+OE$33.72-67,44689,616-43%-$2,274,279
2021-09-17
NAVBNavidea Biopharmaceuticals, Inc.Witter Malcolm GDirP - Purchase$1.60+20,00098,257+26%+$31,952
2021-09-15
LNTHLantheus Holdings, Inc.Sabens AndreaChief Accounting OfficerS - Sale$24.55-1,24266,070-2%-$30,491
2021-09-15
TKNOAlpha Teknova, Inc.Davis TedDir, 10%P - Purchase$27.08+1,4293,573,5590%+$38,697
2021-09-08
TKNOAlpha Teknova, Inc.Davis TedDir, 10%P - Purchase$22.61+1,3003,572,1300%+$29,393
2021-09-08
LNTHLantheus Holdings, Inc.Montagut EtienneChief Business OfficerS - Sale$26.06-45787,262-1%-$11,909
D
2021-09-07
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, CFOS - Sale+OE$180.12-3,4820-100%-$627,178
2021-09-03
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$141.71-6,16719,687-24%-$873,913
DM
2021-08-30
NTLAIntellia Therapeutics, Inc.Leonard John MPres, CEOS - Sale+OE$160.83-121,372777,720-13%-$19,520,418
D
2021-08-30
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific OfficerS - Sale+OE$154.83-97,0002,391-98%-$15,018,054
D
2021-08-30
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical OfficerS - Sale+OE$158.04-2,400791-75%-$379,300
DM
2021-08-30
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, CFOS - Sale+OE$159.45-30,0000-100%-$4,783,538
DM
2021-08-27
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale+OE$686.22-2,5262,975-46%-$1,733,378
A
2021-05-28
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$558.44-2,0002,966-40%-$1,116,884
2021-08-27
MYGNMyriad Genetics IncLambert NicoleSee RemarksS - Sale$34.50-945127,051-1%-$32,603
2021-08-25
TKNOAlpha Teknova, Inc.Davis TedDir, 10%P - Purchase$19.95+9,0903,570,8300%+$181,346
DM
2021-08-23
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$35.32-80,000232,550-26%-$2,825,600
D
2021-08-23
NTLAIntellia Therapeutics, Inc.Leonard John MPres, CEOS - Sale+OE$152.01-27,139777,720-3%-$4,125,416
D
2021-08-19
NTLAIntellia Therapeutics, Inc.Leonard John MPres, CEOS - Sale+OE$151.28-22,682777,720-3%-$3,431,398
2021-08-18
HSKAHeska CorpWisnewski NancyCOOS - Sale$270.33-1,00054,505-2%-$270,331
D
2021-08-17
HSKAHeska CorpLarson Sharon J.DirS - Sale+OE$266.83-2,0007,501-21%-$533,651
DM
2021-08-16
OCDXOrtho Clinical Diagnostics Holdings PlcSchlesinger Michael A.EVP, GC, SecretaryS - Sale+OE$20.13-45,01587,637-34%-$906,124
2021-08-16
LNTHLantheus Holdings, Inc.Sabens AndreaChief Accounting OfficerS - Sale$25.46-1,24267,312-2%-$31,621
M
2021-08-13
IDXXIdexx Laboratories Inc /deMazelsky Jonathan JayPres, CEOS - Sale$675.21-6,00049,427-11%-$4,051,262
DM
2021-08-11
OCDXOrtho Clinical Diagnostics Holdings PlcSchlesinger Michael A.EVP, GC, SecretaryS - Sale+OE$19.80-84,98587,637-49%-$1,682,627
2021-08-11
CLDXCelldex Therapeutics, Inc.Jimenez Freddy A.SVP, GCP - Purchase$46.28+430430New+$19,900
D
2021-08-10
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$679.58-2,4022,896-45%-$1,632,355
2021-08-10
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$25.83-15,580688,182-2%-$402,369
D
2021-08-10
CLDXCelldex Therapeutics, Inc.Martin Samuel BatesSVP, CFOS - Sale+OE$45.25-2,73829,378-9%-$123,895
D
2021-08-09
NTLAIntellia Therapeutics, Inc.Lebwohl DavidEVP, Chief Medical OfficerS - Sale+OE$164.05-2,400791-75%-$393,720
D
2021-08-05
IDXXIdexx Laboratories Inc /deHunt NimrataEVPS - Sale+OE$703.00-5388,266-6%-$378,214
D
2021-08-06
HSKAHeska CorpGrassman CatherineEVP, CFOS - Sale+OE$260.24-5,0003,986-56%-$1,301,210
D
2021-08-04
NTLAIntellia Therapeutics, Inc.Sepp-Lorenzino LauraEVP, Chief Scientific OfficerS - Sale+OE$138.24-26,0002,391-92%-$3,594,357
D
2021-08-05
NTLAIntellia Therapeutics, Inc.Goddard GlennEVP, CFOS - Sale+OE$151.05-20,0000-100%-$3,021,056
D
2021-08-05
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$35.57-28,225232,550-11%-$1,004,008
D
2021-08-05
MYGNMyriad Genetics IncPhanstiel S. LouiseDirS - Sale+OE$35.04-47,881112,646-30%-$1,677,741
2021-08-03
MYGNMyriad Genetics IncRiggsbee Richard BryanCFOS - Sale$35.14-14,983324,942-4%-$526,476
DM
2021-08-03
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$34.68-100,000232,550-30%-$3,467,764
D
2021-08-03
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$34.75-30,00089,527-25%-$1,042,500
DM
2021-08-03
IDXXIdexx Laboratories Inc /deTwigge GiovaniSVPS - Sale+OE$698.25-20,29517,128-54%-$14,170,900
D
2021-08-03
IDXXIdexx Laboratories Inc /deLane MichaelEVPS - Sale+OE$691.62-6,9994,239-62%-$4,840,670
DM
2021-08-02
OCDXOrtho Clinical Diagnostics Holdings PlcYates Robert CliftonDirS - Sale+OE$21.71-341,7425,200-99%-$7,418,265
M
2021-08-02
OCDXOrtho Clinical Diagnostics Holdings PlcSmith Christopher MCOB, CEOS - Sale$21.82-270,000367,360-42%-$5,890,487
2021-07-26
NAVBNavidea Biopharmaceuticals, Inc.Witter Malcolm GDirP - Purchase$1.70+15,00078,257+24%+$25,470
DM
2021-07-12
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$33.64-93,295232,550-29%-$3,138,273
D
2021-07-09
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.62-50,000232,550-18%-$1,631,037
D
2021-07-07
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.27-32,308232,550-12%-$1,042,660
D
2021-06-28
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.39-6,812232,550-3%-$220,608
2021-06-28
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$132.73-553,37610,000-98%-$73,448,879
D
2021-06-25
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$31.96-83,372232,550-26%-$2,664,216
2021-06-16
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$24.37-2,253102,440-2%-$54,912
2021-06-17
MYGNMyriad Genetics IncSpiegelman Daniel KDirS - Sale$30.52-3,13923,129-12%-$95,795
M
2021-06-11
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$87.04-201,7251,127,405-15%-$17,558,774
2021-06-04
LNTHLantheus Holdings, Inc.Montagut EtienneChief Business OfficerS - Sale$24.60-7,43587,719-8%-$182,901
2021-06-04
HSKAHeska CorpWisnewski NancyCOOS - Sale$197.87-5,00055,505-8%-$989,326
2021-05-28
VNRXVolitionrx LtdTerrell Jason Bradley MdChief Medical OfficerS - Sale$3.54-10,00024,949-29%-$35,400
2021-05-28
MYGNMyriad Genetics IncSpiegelman Daniel KDirS - Sale$28.99-7,14213,420-35%-$207,023
2021-05-28
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$558.44-2,0002,986-40%-$1,116,884
D
2021-05-28
IDXXIdexx Laboratories Inc /dePolewaczyk James FEVPS - Sale+OE$561.91-10,00019,915-33%-$5,619,057
D
2021-05-28
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$562.26-9,460654,701-1%-$5,318,989
2021-05-27
ACHVAchieve Life Sciences, Inc.Bencich JohnCEOP - Purchase$7.00+6,0006,141>999%+$42,000
2021-05-24
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$546.24-2,9004,966-37%-$1,584,100
DM
2021-05-24
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$549.57-10,000663,701-1%-$5,495,735
D
2021-05-24
HSKAHeska CorpLarson Sharon J.DirS - Sale+OE$205.00-3,0007,501-29%-$615,000
D
2021-05-21
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$539.57-2,5002,886-46%-$1,348,918
M
2021-05-20
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$540.00-3,0007,866-28%-$1,620,000
D
2021-05-20
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$537.07-5,000663,701-1%-$2,685,324
D
2021-05-18
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$528.02-7,632663,701-1%-$4,029,809

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top